Skip to main content

1 in 5 Patients With Suspected Congenital Hypothyroidism or Resistance to Thyroid Hormone Receive a Molecular Diagnostic Result Using Multi-Gene Panel Testing

Canadian Association of Genetic Councellors
CAGC 2022

Virtual, October 12 - 15, 2022

Poster presentation: 1 in 5 patients with suspected congenital hypothyroidism or resistance to thyroid hormone receive a molecular diagnostic result using multi-gene panel testing

Authors: Scocchia A, Gall K, Hathaway J, du Souich C, Taylor A, Huusko J, Bernal M, Saarinen I, Schleit J, Paananen J, Myllykangas S, Koskenvuo J

Specialties: Cardiovascular, Endocrinology, Genetics


Disclaimer: One or more of the authors of this publication were employed at the time by BluePrint Genetics, a subsidiary of Quest Diagnostics.